ViBA

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.

Visentin R, Giegerich C, Jäger R · Diabetes technology & therapeutics · 2016 · Article

10.1089/dia.2016.0128

Verified evidence

Virtual clinical trial risk comparison

062f3bfb-48d9-5e0b-96ea-a94d1d5cd7a0
Metabolic and biochemical measures

Prediction source Version of record · PDF page(s) 9

Study f6811d8a-0263-5bb6-902a-125e8b3d6161 · Prediction record (JSON)

Prediction fields

Endpoint
low_blood_glucose_index · PDF page(s) 9
Family
glycaemic_control · PDF page(s) 9
Measured variable
low_blood_glucose_index · PDF page(s) 9
Measurement role
physiological_outcome · PDF page(s) 9
Population
human_observations · PDF page(s) 1, 9
Reference type
simulated_against_baseline · PDF page(s) 9
Role
simulated_output · PDF page(s) 9
Scenario
within_model_scenario_comparison · PDF page(s) 9